Healthcare -
Biotechnology - NASDAQ - US
$ 15.5
-6.4 %
$ 2.25 B
Market Cap
-6.03
P/E
DNLI - CASH FROM INVESTING ACTIVITIES
Cash from Investing Activities DNLI - Denali Therapeutics Inc.
249 M
LAST VALUE
267.81%
2 YEAR CAGR
23.45%
5 YEAR CAGR
0.00%
10 YEAR CAGR